The idea that endothelin ETA and ETB receptors may form homodimers and heterodimers has gained increasing interest in recent years. The existence of such interactions between endothelin receptors has the potential to explain some puzzling results from receptor binding and functional studies. Zeng and colleagues take ETB receptor heterodimerization beyond the ETA receptor, reporting renal endothelin ETB-dopamine D 3 receptor interactions at the cellular level that appear to have functional consequences in vivo. Kidney International (2008) 74, 693-694. doi:10.1038/ki.2008 Over the years, a number of studies have reported results concerning the behavior of the two endothelin receptor subtypes, ETA and ETB, that do not fit the classical model of two G protein-coupled receptors acting independently of one another. For example, in the rat anterior pituitary gland, both ETA and ETB receptors are expressed, but competitive binding studies indicated that ETB receptor-selective ligands competed for binding with endothelin-1 (ET-1) only when an ETA receptor-selective ligand was present. 1 Simultaneous blockade of both receptor subtypes was necessary to inhibit clearance of ET-1 by astrocytes, with antagonists of individual receptor subtypes having no effect when administered alone. 2 A similar cooperative interaction between the two receptors, necessitating blockade of both subtypes in order to abolish responses to ET-1, has also been noted in a variety of preparations involving vascular or airway smooth muscle. Systematic experiments by Just and colleagues 3 demonstrated that the contributions of each receptor subtype to the renal vascular effects of ET-1 appear highly complex and are not merely additive. This may not be surprising given differences in receptor expression along the renal vascular tree combined with vasodilator and ET-1 clearance functions of endothelialcell ETB receptors. However, those factors do not adequately explain the observation that either an ETA receptor-selective or an ETB receptor-selective antagonist was able to abolish afferent arteriolar constrictor responses to low concentrations of In recent years, there has been much interest within the endothelin community regarding the possibility that ETA and ETB receptors may form homoand heterodimers. Heterodimerization of endothelin receptors may provide an explanation for the results mentioned in the previous paragraph and might also account for other reports of atypical endothelin binding sites, although splice variants and post-translational modification of receptors should also be considered. It has been demonstrated with the aid of fluorescence resonance energy transfer analysis that, at least in transfected cells, ETA and ETB receptors can constitutively form heterodimers and homodimers. 5, 6 Furthermore, ETB receptors may internalize at a slower rate when present as ETA-ETB heterodimers. 5 This study appears to provide an additional example, albeit an unanticipated one, of the importance of renal ETB receptor function in the normal control of blood pressure and salt and water homeostasis. ETB receptor-deficient rats, collecting duct-specific ETB receptor knockout mice, and rats chronically treated with an ETB receptor antagonist all display an elevation of arterial pressure that is exaggerated when the animals are placed on a high-salt diet. Although these effects may be at least partially attributable to loss of ETB receptor-mediated NO production, the work of Zeng and colleagues 8 would suggest that impairment of D 3 receptor-induced natriuresis might also contribute to the hypertension observed in those animals. Since D 3 and ETB receptors are both expressed by medullary collecting duct cells, it would be interesting to know whether collecting duct-specific ETB receptor knockout mice display reduced diuretic and natriuretic responses to D 3 receptor agonists.
Over the years, a number of studies have reported results concerning the behavior of the two endothelin receptor subtypes, ETA and ETB, that do not fit the classical model of two G protein-coupled receptors acting independently of one another. For example, in the rat anterior pituitary gland, both ETA and ETB receptors are expressed, but competitive binding studies indicated that ETB receptor-selective ligands competed for binding with endothelin-1 (ET-1) only when an ETA receptor-selective ligand was present. 1 Simultaneous blockade of both receptor subtypes was necessary to inhibit clearance of ET-1 by astrocytes, with antagonists of individual receptor subtypes having no effect when administered alone. 2 A similar cooperative interaction between the two receptors, necessitating blockade of both subtypes in order to abolish responses to ET-1, has also been noted in a variety of preparations involving vascular or airway smooth muscle. Systematic experiments by Just and colleagues 3 demonstrated that the contributions of each receptor subtype to the renal vascular effects of ET-1 appear highly complex and are not merely additive. This may not be surprising given differences in receptor expression along the renal vascular tree combined with vasodilator and ET-1 clearance functions of endothelialcell ETB receptors. However, those factors do not adequately explain the observation that either an ETA receptor-selective or an ETB receptor-selective antagonist was able to abolish afferent arteriolar constrictor responses to low concentrations of ET-1. 4 In recent years, there has been much interest within the endothelin community regarding the possibility that ETA and ETB receptors may form homoand heterodimers. Heterodimerization of endothelin receptors may provide an explanation for the results mentioned in the previous paragraph and might also account for other reports of atypical endothelin binding sites, although splice variants and post-translational modification of receptors should also be considered. It has been demonstrated with the aid of fluorescence resonance energy transfer analysis that, at least in transfected cells, ETA and ETB receptors can constitutively form heterodimers and homodimers. 5, 6 Furthermore, ETB receptors may internalize at a slower rate when present as ETA-ETB heterodimers. 5 Consistent with this effect, HEK 293 cells transfected with both ETA and ETB receptors display a markedly prolonged (>4 minutes) increase in [Ca 2+ ] in response to exposure to ET-1 or the selective ETB receptor antagonist sarafotoxin 6c, compared with more transient (1-2 minutes) responses of cells transfected with either receptor subtype alone. 7 At least with endothelin receptors, most work to date has focused on hetero dimerization of ETA and ETB receptors, rather than heterodimerization of endothelin receptors with receptors that bind other ligands. However, multiple combinations of receptor hetero dimers have been described over the past 20 years, including dimers that bind the same ligand (for example, β 2 -adrenoceptor-α 2 -adrenoceptor dimers) or different ligands (for example, angiotensin AT 1 -bradykinin B 2 receptor dimers). 7 Heterodimerization of receptors alters their ligand-binding properties and in some cases appears essential for activation of downstream signaling. 7 Zeng and colleagues 8 This study appears to provide an additional example, albeit an unanticipated one, of the importance of renal ETB receptor function in the normal control of blood pressure and salt and water homeostasis. ETB receptor-deficient rats, collecting duct-specific ETB receptor knockout mice, and rats chronically treated with an ETB receptor antagonist all display an elevation of arterial pressure that is exaggerated when the animals are placed on a high-salt diet. Although these effects may be at least partially attributable to loss of ETB receptor-mediated NO production, the work of Zeng and colleagues 8 would suggest that impairment of D 3 receptor-induced natriuresis might also contribute to the hypertension observed in those animals. Since D 3 and ETB receptors are both expressed by medullary collecting duct cells, it would be interesting to know whether collecting duct-specific ETB receptor knockout mice display reduced diuretic and natriuretic responses to D 3 receptor agonists.
Although further experiments are needed to determine definitively whether D 3 -ETB receptor heterodimers exist, for example, by using fluorescence resonance energy transfer analysis or coimmunoprecipitation of receptors, the results of the study by Zeng and colleagues 8 appear to indicate that D 3 -ETB receptor interactions in the renal tubules facilitate D 3 agonist-induced natriuresis. Zeng and colleagues have previously reported that ETB and AT 1 receptors can be co-immuno precipitated from SHR and WKY renal proximal tubular cells. 9, 10 Although Zeng and colleagues reported that stimulation of either the ETB or the AT 1 receptor resulted in changes in expression and phosphorylation of the other receptor, 9,10 the physiological consequences of these ETB-AT 1 receptor interactions were not directly addressed. An intriguing possibility is that endothelin receptor-AT 1 receptor heterodimerization could be one of the mechanisms underlying the reported ability of endothelin receptor antagonists to attenuate or abolish acute and chronic effects of angiotensin II (see, for example, Riggleman et al. 11 ). Several studies suggest that ETA receptor activation may impair α 1 -adrenoceptor-mediated responses. 12, 13 However, this appears to occur, at least in fibroblasts, via phosphorylation of the α 1 -adrenoceptor, 14 and, as ET-1 did not stimulate internalization of the α 1 -adrenoceptor, this effect may not involve the existence of ETA receptor-α 1 -adrenoceptor heterodimers. A pictorial summary of the endothelin receptor dimers proposed to date is given in Figure 1 . Whether endothelin receptors form hetero dimers with any other receptors, and the functional consequences of any such interactions, remains an open field of future inquiry.
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